7 Oct
2021

Four IP takeaways from Merck’s $11.5 billion Acceleron acquisition

Merck has struck the biggest life sciences M&A deal of 2021 so far. Here are the four key IP-related takeaways.

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth